These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 37186836)

  • 21. Neutral Sphingomyelinase-2 Deficiency Ameliorates Alzheimer's Disease Pathology and Improves Cognition in the 5XFAD Mouse.
    Dinkins MB; Enasko J; Hernandez C; Wang G; Kong J; Helwa I; Liu Y; Terry AV; Bieberich E
    J Neurosci; 2016 Aug; 36(33):8653-67. PubMed ID: 27535912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of LDL receptor enhances amyloid deposition and decreases glial response in an Alzheimer's disease mouse model.
    Katsouri L; Georgopoulos S
    PLoS One; 2011; 6(7):e21880. PubMed ID: 21755005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attenuation of Alzheimer's brain pathology in 5XFAD mice by PTH
    Chen L; Xiong L; Yao L; Pan J; Arzola E; Zhu X; Mei L; Xiong WC
    Alzheimers Res Ther; 2023 Mar; 15(1):53. PubMed ID: 36918976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of phagocytic activity in astrocytes by reduced expression of the inflammasome component ASC and its implication in a mouse model of Alzheimer disease.
    Couturier J; Stancu IC; Schakman O; Pierrot N; Huaux F; Kienlen-Campard P; Dewachter I; Octave JN
    J Neuroinflammation; 2016 Jan; 13():20. PubMed ID: 26818951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Astrocyte-specific knockout of YKL-40/Chi3l1 reduces Aβ burden and restores memory functions in 5xFAD mice.
    Zeng X; Cheung SKK; Shi M; Or PMY; Li Z; Liu JYH; Ho WLH; Liu T; Lu K; Rudd JA; Wang Y; Chan AM
    J Neuroinflammation; 2023 Dec; 20(1):290. PubMed ID: 38042775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
    Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
    J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Islet amyloid polypeptide (IAPP): a second amyloid in Alzheimer's disease.
    Fawver JN; Ghiwot Y; Koola C; Carrera W; Rodriguez-Rivera J; Hernandez C; Dineley KT; Kong Y; Li J; Jhamandas J; Perry G; Murray IV
    Curr Alzheimer Res; 2014; 11(10):928-40. PubMed ID: 25387341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic Deletion of Tumor Necrosis Factor-α Attenuates Amyloid-β Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease.
    Paouri E; Tzara O; Zenelak S; Georgopoulos S
    J Alzheimers Dis; 2017; 60(1):165-181. PubMed ID: 28826177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual pathways mediate β-amyloid stimulated glutathione release from astrocytes.
    Ye B; Shen H; Zhang J; Zhu YG; Ransom BR; Chen XC; Ye ZC
    Glia; 2015 Dec; 63(12):2208-19. PubMed ID: 26200696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deletion of the Inflammasome Sensor Aim2 Mitigates Aβ Deposition and Microglial Activation but Increases Inflammatory Cytokine Expression in an Alzheimer Disease Mouse Model.
    Wu PJ; Hung YF; Liu HY; Hsueh YP
    Neuroimmunomodulation; 2017; 24(1):29-39. PubMed ID: 28618410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting isoaspartate-modified Aβ rescues behavioral deficits in transgenic mice with Alzheimer's disease-like pathology.
    Gnoth K; Piechotta A; Kleinschmidt M; Konrath S; Schenk M; Taudte N; Ramsbeck D; Rieckmann V; Geissler S; Eichentopf R; Barendrecht S; Hartlage-Rübsamen M; Demuth HU; Roßner S; Cynis H; Rahfeld JU; Schilling S
    Alzheimers Res Ther; 2020 Nov; 12(1):149. PubMed ID: 33189132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulation of Alzheimer's Disease Amyloid-β Protein Precursor in Astrocytes Both in vitro and in vivo.
    Liang Y; Raven F; Ward JF; Zhen S; Zhang S; Sun H; Miller SJ; Choi SH; Tanzi RE; Zhang C
    J Alzheimers Dis; 2020; 76(3):1071-1082. PubMed ID: 32597805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SGLT2 and DPP4 inhibitors improve Alzheimer's disease-like pathology and cognitive function through distinct mechanisms in a T2D-AD mouse model.
    Sim AY; Choi DH; Kim JY; Kim ER; Goh AR; Lee YH; Lee JE
    Biomed Pharmacother; 2023 Dec; 168():115755. PubMed ID: 37871560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease.
    Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL
    Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FoxO3 deficiency in cortical astrocytes leads to impaired lipid metabolism and aggravated amyloid pathology.
    Du S; Jin F; Maneix L; Gedam M; Xu Y; Catic A; Wang MC; Zheng H
    Aging Cell; 2021 Aug; 20(8):e13432. PubMed ID: 34247441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuronal and Astrocytic Extracellular Vesicle Biomarkers in Blood Reflect Brain Pathology in Mouse Models of Alzheimer's Disease.
    Delgado-Peraza F; Nogueras-Ortiz CJ; Volpert O; Liu D; Goetzl EJ; Mattson MP; Greig NH; Eitan E; Kapogiannis D
    Cells; 2021 Apr; 10(5):. PubMed ID: 33922642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alzheimer's disease-associated β-amyloid does not protect against herpes simplex virus 1 infection in the mouse brain.
    Bocharova O; Pandit NP; Molesworth K; Fisher A; Mychko O; Makarava N; Baskakov IV
    J Biol Chem; 2021 Jul; 297(1):100845. PubMed ID: 34052228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alzheimer amyloid-β- peptide disrupts membrane localization of glucose transporter 1 in astrocytes: implications for glucose levels in brain and blood.
    Hendrix RD; Ou Y; Davis JE; Odle AK; Groves TR; Allen AR; Childs GV; Barger SW
    Neurobiol Aging; 2021 Jan; 97():73-88. PubMed ID: 33161213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective effects of CCL01 against Aβ-induced neurotoxicity in 5xFAD transgenic mouse model of Alzheimer's disease.
    Ju IG; Son SY; Lee S; Im H; Huh E; Eo H; Choi JG; Sohn MW; Yim SV; Kim SY; Kim DH; Lee CH; Oh MS
    Biomed Pharmacother; 2023 Feb; 158():114105. PubMed ID: 36508997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A combination Alzheimer's therapy targeting BACE1 and neprilysin in 5XFAD transgenic mice.
    Devi L; Ohno M
    Mol Brain; 2015 Mar; 8():19. PubMed ID: 25884928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.